RQX Pharmaceuticals, Inc.
Records under this name other than the patents RQX Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to RQX Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,392,422 | Macrocyclic Broad Spectrum Antibiotics now held by Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 11,072,635 | Macrocyclic Broad Spectrum Antibiotics now held by Genentech, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,999,922 | Linear Peptide Antibiotics Lapsed on the fee record Ended Apr 7, 2023 · High confidence | Lapsed on the fee record | Ended Apr 7, 2023 | High confidence |
| US 9,708,368 | Linear Peptide Antibiotics Lapsed on the fee record Ended Jul 18, 2021 · Medium confidence | Lapsed on the fee record | Ended Jul 18, 2021 | Medium confidence |
| 14/123,024 | Broad Spectrum Antibiotics Abandoned Abandoned Dec 15, 2016 | Abandoned | Abandoned Dec 15, 2016 | |
| 14/911,823 | Linear Peptide Antibiotcs now held by Genentech, Inc. Abandoned Abandoned Aug 1, 2019 | Abandoned | Abandoned Aug 1, 2019 | |
| 15/618,337 | Linear Peptide Antibiotics Abandoned Abandoned Feb 26, 2018 | Abandoned | Abandoned Feb 26, 2018 | |
| 15/777,499 | Macrocyclic Broad Spectrum Antibiotics now held by Genentech, Inc. Abandoned Abandoned Sep 20, 2021 | Abandoned | Abandoned Sep 20, 2021 | |
| 16/539,947 | Macrocyclic Broad Spectrum Antibiotics now held by Genentech, Inc. Abandoned Abandoned Nov 17, 2022 | Abandoned | Abandoned Nov 17, 2022 | |
| 17/477,277 | Macrocyclic Broad Spectrum Antibiotics now held by Genentech, Inc. Abandoned Abandoned May 16, 2022 | Abandoned | Abandoned May 16, 2022 |